Eusol Biotech Co.,Ltd. (TPEX:6652)
3.810
-0.480 (-11.19%)
Mar 25, 2026, 12:00 PM CST
Eusol Biotech Market Cap
Eusol Biotech has a market cap or net worth of 587.73 million as of March 24, 2026. Its market cap has decreased by -46.31% in one year.
Market Cap
587.73M
Enterprise Value
262.05M
Revenue
370.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
3.81
Market Cap Chart
Since August 29, 2018, Eusol Biotech's market cap has decreased from 5.42B to 587.73M, a decrease of -89.16%. That is a compound annual growth rate of -25.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 587.73M | -27.41% |
| Dec 31, 2025 | 809.67M | -26.13% |
| Dec 31, 2024 | 1.10B | -15.43% |
| Dec 29, 2023 | 1.30B | 16.79% |
| Dec 30, 2022 | 1.11B | -45.27% |
| Dec 30, 2021 | 2.03B | -35.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lukas Biomedical | 1.11B |
| GeneReach Biotechnology | 1.09B |
| Level Biotechnology | 1.08B |
| Holy Stone Healthcare | 1.03B |
| TCI GENE | 965.74M |
| Taiwan Advance Bio-Pharmaceutical | 936.00M |
| NatureWise Biotech & Medicals | 916.55M |
| Neith | 899.73M |